Here’s Why Shockwave Medical (SWAV) Surged in Q1
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Shockwave Medical Inc. (SWAV)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 495,358 | $161,303,426 | -45% | 0.03% |
| 2. | Millennium Management Israel Englander | 338,977 | $110,381,081 | +46% | 0.04% |
| 3. | Point72 Asset Management Steve Cohen | 287,852 | $93,733,247 | 0.22% | |
| 4. | Balyasny Asset Management Dmitry Balyasny | 216,318 | $70,439,630 | +158% | 0.12% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 154,801 | $50,407,852 | -33% | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.00 | 10,000 | Large Shareholder, Other | 10,000 | 2019-03-11 | Filing | |
| $17.00 | 10,000 | Large Shareholder, Other | 166,073 | 2019-03-11 | Filing | |
| $17.00 | 10,000 | Large Shareholder, Other | 166,073 | 2019-03-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $300.00 | 1,500 | Director | 3,551 | 2024-03-26 | Filing | |
| $287.67 | 4,000 | Officer | 56,818 | 2024-03-26 | Filing | |
| $254.57 | 700 | Director | 4,532 | 2024-03-06 | Filing | |
| $253.15 | 1,300 | Director | 5,232 | 2024-03-06 | Filing | |
| $253.14 | 21 | Officer | 31,024 | 2024-03-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,722,157 | $709,294,237 | 0.01% | |
| 2. | 3,633,720 | $692,441,683 | 0.01% | |
| 3. | 2,470,419 | $470,763,045 | 0.08% | |
| 4. | 2,000,216 | $381,161,226 | 0.02% | |
| 5. | 1,495,492 | $284,980,956 | 0.43% |
News See All
Shockwave Medical (SWAV) Rose on an Acquisition News and Solid Financial Result
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in.
Shockwave Medical (SWAV) Rose on Strong Financial Results
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Does Shockwave Medical (SWAV) Have Strong Outlook for 2024?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.
ShockWave Medical, Inc. (NASDAQ:SWAV) Q4 2023 Earnings Call Transcript
ShockWave Medical, Inc. beats earnings expectations. Reported EPS is $1.16, expectations were $0.92. ShockWave Medical, Inc.
14 High Growth NASDAQ Stocks That Are Profitable
In this article, we will take a detailed look at the 14 High Growth NASDAQ Stocks That Are Profitable. For a quick overview of such stocks, read our article 5 High Growth NASDAQ Stocks That Are Profitable...
16 Best Mid-Cap Growth Stocks To Buy Now
Investors are hopeful that small- and mid-cap stocks will experience a broader rally this year after getting hammered for most part of the previous year as all eyes remain focused on the Magnificent Seven...
13 High Growth Healthcare Stocks to Buy
In this article, we will take a look at 13 high growth healthcare stocks to buy.
What Makes Shockwave Medical (SWAV) a Potential Investment?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
